<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00581048</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#051158</org_study_id>
    <secondary_id>5K23HL080030-02</secondary_id>
    <nct_id>NCT00581048</nct_id>
  </id_info>
  <brief_title>Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics</brief_title>
  <official_title>Oxidant Stress and Allergic Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma is a common respiratory disease of unknown etiology which currently affects
      approximately 7.5 % of the adult population ( ). Asthma is an inflammatory disorder of the
      airways. Airway inflammation is evident not only in patients with fatal asthma but also in
      mild asthmatics ( ). Oxidant stress, defined as inadequately controlled generation of toxic
      reactive oxygen species (ROS) in the cells or tissues is a common feature of inflammation,
      and has also been documented in asthma ( , ). However, the current understanding of the
      relationship between the inflammation and the oxidant stress in asthmatic airways is poor.
      Does oxidant stress contribute to the expression of asthmatic phenotypes independently of
      inflammation? If so, could asthmatics benefit from supplementation of antioxidants? These
      questions have been nagging us since our laboratory provided credible evidence of oxidant
      injury in the airways of allergic asthmatics ( ). The purpose of our study is to more
      precisely determine 1/ the pathophysiologic role of oxidative stress, and 2/ usefulness of
      antioxidant therapy using vitamin E in allergic asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Natural-source d-α-tocopheryl Acetate on the Baseline and Allergen-induced Levels of F2-isoprostanes in the Bronchoalveolar Lavage Fluid (BAL)</measure>
    <time_frame>At baseline to after 16-18 weeks of treatment with vitamin E daily</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Treatment With Vitamin E on Airway Reactivity to Methacholine</measure>
    <time_frame>At baseline and After 16-18 weeks of treatment with vitamin E</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergen-provoked Concentrations of Th1 and Th2 Cytokines in BAL</measure>
    <time_frame>baseline to after 16-18 weeks of treatment with vitamin E daily</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergen-provoked Concentrations of Immunoglobulin E (IgE) in BAL</measure>
    <time_frame>baseline to after 16-18 weeks of treatment with vitamin E daily</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Allergic Asthma</condition>
  <arm_group>
    <arm_group_label>Natural source d-α-tocopheryl acetate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1500 units daily for 16 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Natural source d-α-tocopheryl acetate</intervention_name>
    <description>1500 units daily for 16 weeks</description>
    <arm_group_label>Natural source d-α-tocopheryl acetate</arm_group_label>
    <other_name>Vitamin E</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal health status except for allergic asthma

          -  Physician diagnosis of mild allergic asthma

          -  Positive allergen skin tests to common aeroallergens

        Exclusion Criteria:

          -  Use of systemic or high doses of inhaled corticosteroids, &gt;840 mcg of inhaled
             beclomethasone of its equivalent (as defined in the consensus report (6))

          -  Past history of severe asthma (as defined in the consensus report (6))

          -  History of asthma exacerbation within the past month

          -  History of recent upper respiratory infection within the past month

          -  Active immunotherapy for allergic diseases

          -  Significant disease other than allergic asthma and allergic rhinitis, such as coronary
             disease, hypertension, renal failure, anemia, immunodeficiency, cancer, diabetes

          -  Present or remote tobacco smoking

          -  Use of Over The Counter drugs including acetaminophen and pseudoephedrine, herbs, or
             vitamins

          -  Psychiatric illness that would make adherence to protocol difficult

          -  Inability to give informed consent

          -  Nursing or pregnant women

          -  Woman planning to become pregnant during the study or not using adequate birth control
             methods (barrier or hormonal methods)

          -  H/o sensitivity to tocopherol-derivatives or medications used during bronchoscopy

          -  Inability to comply with the research protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryszard Dworski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dep. of Medicine, Div. of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-2650</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2007</study_first_submitted>
  <study_first_submitted_qc>December 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2007</study_first_posted>
  <results_first_submitted>January 10, 2018</results_first_submitted>
  <results_first_submitted_qc>January 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 6, 2018</results_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Ryszard T. Dworski</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Allergy</keyword>
  <keyword>Atopy</keyword>
  <keyword>Vitamin E</keyword>
  <keyword>GSTP1</keyword>
  <keyword>Oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Natural Source d-α-tocopheryl Acetate</title>
          <description>1500 units daily for 16 weeks
Natural source d-α-tocopheryl acetate: 1500 units daily for 16 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Natural Source d-α-tocopheryl Acetate</title>
          <description>1500 units daily for 16 weeks
Natural source d-α-tocopheryl acetate: 1500 units daily for 16 weeks</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effect of Natural-source d-α-tocopheryl Acetate on the Baseline and Allergen-induced Levels of F2-isoprostanes in the Bronchoalveolar Lavage Fluid (BAL)</title>
        <time_frame>At baseline to after 16-18 weeks of treatment with vitamin E daily</time_frame>
        <population>Underlying data was lost. Go to https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476459 Figure 1 for diagram of results</population>
        <group_list>
          <group group_id="O1">
            <title>Before Treatment, Baseline</title>
          </group>
          <group group_id="O2">
            <title>After Treatment</title>
          </group>
        </group_list>
        <measure>
          <title>Effect of Natural-source d-α-tocopheryl Acetate on the Baseline and Allergen-induced Levels of F2-isoprostanes in the Bronchoalveolar Lavage Fluid (BAL)</title>
          <population>Underlying data was lost. Go to https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476459 Figure 1 for diagram of results</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect of Treatment With Vitamin E on Airway Reactivity to Methacholine</title>
        <time_frame>At baseline and After 16-18 weeks of treatment with vitamin E</time_frame>
        <population>Underlying data was lost. Go to https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476459 Figure 2 for diagram of results</population>
        <group_list>
          <group group_id="O1">
            <title>Before Treatment, Baseline</title>
          </group>
          <group group_id="O2">
            <title>After Treatment</title>
          </group>
        </group_list>
        <measure>
          <title>Effect of Treatment With Vitamin E on Airway Reactivity to Methacholine</title>
          <population>Underlying data was lost. Go to https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476459 Figure 2 for diagram of results</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Allergen-provoked Concentrations of Th1 and Th2 Cytokines in BAL</title>
        <time_frame>baseline to after 16-18 weeks of treatment with vitamin E daily</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before Treatment, Baseline</title>
          </group>
          <group group_id="O2">
            <title>After Treatment</title>
          </group>
        </group_list>
        <measure>
          <title>Allergen-provoked Concentrations of Th1 and Th2 Cytokines in BAL</title>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-1B</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" lower_limit="0.3" upper_limit="1.69"/>
                    <measurement group_id="O2" value="1.21" lower_limit="0.52" upper_limit="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" lower_limit="0.2" upper_limit="0.99"/>
                    <measurement group_id="O2" value="0.69" lower_limit="0.23" upper_limit="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" lower_limit="0" upper_limit="7.7"/>
                    <measurement group_id="O2" value="1.4" lower_limit="0" upper_limit="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" lower_limit="0.03" upper_limit="0.57"/>
                    <measurement group_id="O2" value="0.045" lower_limit="0" upper_limit="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" lower_limit="0.33" upper_limit="2.9"/>
                    <measurement group_id="O2" value="0.8" lower_limit="0.41" upper_limit="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.5" lower_limit="5.55" upper_limit="111.9"/>
                    <measurement group_id="O2" value="17" lower_limit="4.35" upper_limit="94.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="6.25"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" lower_limit="0.29" upper_limit="1.09"/>
                    <measurement group_id="O2" value="0.7" lower_limit="0.25" upper_limit="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" lower_limit="0.002" upper_limit="0.21"/>
                    <measurement group_id="O2" value="0.165" lower_limit="0.078" upper_limit="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" lower_limit="0.4" upper_limit="1.96"/>
                    <measurement group_id="O2" value="1.0" lower_limit="0.075" upper_limit="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TNF-a</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.76" lower_limit="0.65" upper_limit="11.6"/>
                    <measurement group_id="O2" value="3.02" lower_limit="0.96" upper_limit="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>INF-Y</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" lower_limit="0.23" upper_limit="0.96"/>
                    <measurement group_id="O2" value="0.7" lower_limit="0.3" upper_limit="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CXCL8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.0" lower_limit="25.2" upper_limit="93.5"/>
                    <measurement group_id="O2" value="53.2" lower_limit="31.0" upper_limit="92.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CCL5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="1.36" upper_limit="7.11"/>
                    <measurement group_id="O2" value="2.3" lower_limit="1.71" upper_limit="8.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CCL11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" lower_limit="0" upper_limit="4.02"/>
                    <measurement group_id="O2" value="2.70" lower_limit="0" upper_limit="5.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Allergen-provoked Concentrations of Immunoglobulin E (IgE) in BAL</title>
        <time_frame>baseline to after 16-18 weeks of treatment with vitamin E daily</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Before Treatment, Baseline</title>
          </group>
          <group group_id="O2">
            <title>After Treatment</title>
          </group>
        </group_list>
        <measure>
          <title>Allergen-provoked Concentrations of Immunoglobulin E (IgE) in BAL</title>
          <units>UI/ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.05" lower_limit="2.81" upper_limit="10.8"/>
                    <measurement group_id="O2" value="3.65" lower_limit="2.87" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Natural Source d-α-tocopheryl Acetate</title>
          <description>1500 units daily for 16 weeks
Natural source d-α-tocopheryl acetate: 1500 units daily for 16 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ryszard Dworski</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>615-322-3412</phone>
      <email>ryszard.dworski@Vanderbilt.Edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

